EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer. [electronic resource]
Producer: 20200609Description: 1311-1320 p. digitalISSN:- 1569-8041
- Aged
- Alleles
- Antineoplastic Agents, Immunological -- pharmacology
- B7-H1 Antigen -- antagonists & inhibitors
- Biomarkers, Tumor -- antagonists & inhibitors
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Drug Resistance, Neoplasm -- genetics
- ErbB Receptors -- antagonists & inhibitors
- Female
- Genetic Heterogeneity
- Humans
- Lung -- immunology
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Progression-Free Survival
- Retrospective Studies
- Tobacco Smoking -- adverse effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.